Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Manggung Polahraya Tbk. (MANG) Price & Performance

UBC Medical Indonesia Tbk.Trade
Manggung Polahraya Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Manggung Polahraya Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Manggung Polahraya Tbk. trades at Rp38 (market cap 144.88B, 3.11M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.5× Manggung Polahraya Tbk.'s market cap, and Manggung Polahraya Tbk. is more actively traded (3.11M versus 848.2K). Which is the better fit depends on your goals.

LABSMANG
Market Cap
651.75B144.88B
Volume
848.2K3.11M
Lot
8.48K31.15K
Turnover
140.51M116.3M
Average Price
165.6637.34
Value
140.51M116.3M
Indicative Equilibrium Price
16838
Indicative Equilibrium Volume
505

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MANG
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Manggung Polahraya Tbk.

PT Manggung Polahraya Tbk (Company) was established in Jakarta based on notarial deed No. 3 dated February 5, 1992, which was made by Esther Mercia Sulaiman, S.H., notary in Cianjur.

Read more on MANG